Trade Summary
Yesterday, Patel Sujal M, serving as CEO, Pres,, Secretary, 10% owner at Nautilus Biotechnology, Inc. (NAUT), purchased 25,000 shares at $2.61 per share, for a total transaction value of $65,238.00. Following this transaction, Patel Sujal M now holds 17,461,232 shares of NAUT.
The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, meaning the disclosure happened on the same day as the trade.
Nautilus Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.